Nina Bauer

Senior Director, Head of Commercial, Gene Therapy • MilliporeSigma

Dr. Nina Bauer is the Head of Commercial for the Gene Editing and Novel Modalities Business at MilliporeSigma, responsible for a significant cell and gene therapy product and services portfolio, including the Viral Vector CDMO offering and substantial gene editing IP centered around CRISPR-Cas9 assets. Nina’s background is in the Cell and Gene Therapy manufacturing space, with prior stints as Lonza’s Head of Autologous Cell Therapy, FloDesign Sonics’ Chief Commercial Officer, and at the Cell and Therapy Catapult in London, initiating its European business. Nina holds a PhD in Neuroscience, and an MBA.

Also Speaking

Jeff Boyd

Partner and Life Sciences Tools & Services Sector Co-Leader • Heidrick & Struggles

Emma Cheesman

Director of Development Consulting and Scientific Affairs • BioPharma Excellence

Kent Thorup

Regional Vice President of Business Development • QuickSTAT Global Life Science Logistics

Event Info


Fun Run